Table 2.
Univariate analysis of AKI with clinical characteristics among cancer patients during admissions.
| Variables | Total frequency (%) | AKI +ve frequency (%) | AKI −ve frequency (%) | P value∗ |
|---|---|---|---|---|
| IV contrast use | ||||
| Yes | 80 (12.5%) | 4 (5%) | 76 (95%) | .474 |
| No | 558 (87.5%) | 40 (7.2%) | 518 (92.8%) | |
| Antibiotic use | ||||
| Yes | 250 (39.2%) | 31 (12.4%) | 219 (87.6%) | <.001 |
| No | 388 (60.8%) | 13 (3.4%) | 375 (96.6%) | |
| Chemotherapy use | ||||
| Yes | 320 (50.2%) | 13 (4.1%) | 301 (95.9%) | .015 |
| No | 315 (49.5%) | 31 (9.8%) | 284 (90.2%) | |
| Radiotherapy | ||||
| Yes | 24 (3.8%) | 2 (8.3%) | 22 (91.7%) | .777 |
| No | 614 (96.2%) | 42 (6.8%) | 572 (93.2%) | |
| Hypercalcemia | ||||
| Yes | 7 (1.1%) | 3 (42.9%) | 4 (57.1%) | <.001 |
| No | 631 (98.9%) | 41 (6.5%) | 590 (93.5%) | |
| Sepsis | ||||
| Yes | 90 (14.1%) | 20 (22.2%) | 70 (77.8%) | <.001 |
| No | 548 (85.9%) | 24 (4.4%) | 524 (95.6%) |
∗Chi-square test.